Biological and clinical relevance of Laminin-5 in cancer

Clinical and Experimental Metastasis

Volumn 18, Issue 6, 2000, Pages 439-443

  Giannelli, Gianluigi ^a   Antonaci, Salvatore ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Cancer; Extracellular matrix; Laminin 5; Metastasis; MMP 2

Indexed keywords

GELATINASE A; KALININ; MATRIX METALLOPROTEINASE INHIBITOR; PROTEINASE; SCLEROPROTEIN;

BASEMENT MEMBRANE; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CELL MIGRATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HEMIDESMOSOME; METASTASIS; PROGNOSIS; REVIEW;

CELL ADHESION MOLECULES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASM METASTASIS; NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0034858098     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011879900554     Document Type: Review

References (50)

1. Metastatic potential correlates with enzymatic degradation of basement membrane collagen
2. Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade
3. Matrix metalloproteinases and the development of cancer
4. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate
5. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
6. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2
7. Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions
8. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2
9. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface
10. Tumor cell interactions with the extracellular matrix during invasion and metastasis
11. Molecular insights into cancer invasion: Strategies for prevention and intervention
12. Focalized proteolysis: Spatial and temporal regulation of extracellular matrix degradation at the cell surface
13. A matrix metalloproteinase expressed on the surface of invasive tumour cells
14. A new nomenclature for the laminins
15. Structural requirement for cell adhesion to kalinin (laminin-5)
16. Basement membrane proteins kalinin and nicein are structurally and immunologically identical
17. Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease
18. Anchorage mediated by integrin alpha6beta4 to laminin 5 (epiligrin) regulates tyrosine phosphorylation of a membrane-associated 80-kD protein
19. A function for the integrin alpha 6 beta 4 in the hemidesmosome
20. Junctional epidermolysis bullosis: Detects in expression of epiligrin/nicein/kalinin and integrin beta 4 that inhibit hemidesmosome formation
21. Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients
22. Defective integrin alpha 6 beta 4 expression in the skin of patients with junctional epidermolysis bullosa and pyloric atresia
23. Altered laminin 5 expression due to mutations in the gene encoding the beta 3 chain (LAMB3) in generalized atrophic benign epidermolysis bullosa
24. A large cell-adhesive scatter factor secreted by human gastric carcinoma cells
25. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes
26. Deposition of laminin 5 in epidermal wounds regulates integrin signaling and adhesion
27. Cloning of the LamA3 gene encoding the alpha 3 chain of the adhesive ligand epiligrin. Expression in wound repair
28. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5
29. Structural requirement of carboxyl-terminal globular domains of laminin a3 chain for promotion of rapid cell adhesion and migration by laminin-5
30. Laminin-5 promotes adhesion and migration of epithelial cells: Identification of a migration-related element in the gamma2 chain gene (LAMC2) with activity in transgenic mice
31. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5
32. Functional re-expression of laminin-5 in laminin-gamma2-deficient human keratinocytes modifies cell morphology, motility, and adhesion
33. High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis
34. Processing of laminin-5 and its functional consequences: Role of plasmin and tissue-type plasminogen activator
35. Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids
36. The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers
37. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas
38. Overexpression of laminin gamma2 chain monomer in invading gastric carcinoma cells
39. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma
40. Clinico-pathologic significance of laminin-5 gamma2 chain expression in squamous cell carcinoma of the tongue: Immunohistochemical analysis of 67 lesions
41. Expression of the laminin gamma2 chain in different histological types of lung carcinoma. A study by immunohistochemistry and in situ hybridization
42. Expression of the laminin gamma 2 chain in pancreatic adenocarcinoma
43. Laminin-5 as a marker of invasiveness in cervical lesions
44. A rapid in vitro assay for quantitating the invasive potential of tumor cells
45. Integrin alpha3beta1-mediated interaction with laminin-5 stimulates adhesion, migration and invasion of malignant glioma cells
46. Down-regulation of laminin-5 in breast carcinoma cells
47. Loss of laminin-5 in the epithelium-stroma interface: An immunohistochemical marker of malignancy in epithelial lesions of the breast
48. Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate
49. Human hepatocellular carcinoma (HCC) cells require both α3β1 integrin and matrix metalloproteinases activity for migration and invasion
50. Tumor cell budding and laminin-5 expression in colorectal carcinoma can be modulated by the tissue micro-environment